These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28198705)

  • 1. DM1 Patients with Small CTG Expansions are also at Risk of Severe Conduction Abnormalities.
    Denicourt M; Pham MT; Mathieu J; Breton R
    J Neuromuscul Dis; 2015; 2(1):99-105. PubMed ID: 28198705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1.
    Groh WJ; Groh MR; Saha C; Kincaid JC; Simmons Z; Ciafaloni E; Pourmand R; Otten RF; Bhakta D; Nair GV; Marashdeh MM; Zipes DP; Pascuzzi RM
    N Engl J Med; 2008 Jun; 358(25):2688-97. PubMed ID: 18565861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy.
    Nazarian S; Wagner KR; Caffo BS; Tomaselli GF
    Pacing Clin Electrophysiol; 2011 Feb; 34(2):171-6. PubMed ID: 20946286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre.
    Bucci E; Testa M; Licchelli L; Frattari A; El Halabieh NA; Gabriele E; Pignatelli G; De Santis T; Fionda L; Vanoli F; Morino S; Garibaldi M; Di Pasquale A; Vanacore N; Botta A; Antonini G
    J Neurol; 2018 Apr; 265(4):885-895. PubMed ID: 29429070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?
    Clarke NR; Kelion AD; Nixon J; Hilton-Jones D; Forfar JC
    Heart; 2001 Oct; 86(4):411-6. PubMed ID: 11559681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry.
    Chong-Nguyen C; Wahbi K; Algalarrondo V; Bécane HM; Radvanyi-Hoffman H; Arnaud P; Furling D; Lazarus A; Bassez G; Béhin A; Fayssoil A; Laforêt P; Stojkovic T; Eymard B; Duboc D
    Circ Cardiovasc Genet; 2017 Jun; 10(3):. PubMed ID: 28611030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of atrio-ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types I and II.
    Ha AH; Tarnopolsky MA; Bergstra TG; Nair GM; Al-Qubbany A; Healey JS
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1262-9. PubMed ID: 22385162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length.
    Groh WJ; Lowe MR; Zipes DP
    J Cardiovasc Electrophysiol; 2002 May; 13(5):444-8. PubMed ID: 12030525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Manifestations of Myotonic Dystrophy in a Pediatric Cohort.
    Brunet Garcia L; Hajra A; Field E; Wacher J; Walsh H; Norrish G; Manzur A; Muntoni F; Munot P; Robb S; Quinlivan R; Scoto M; Baranello G; Sarkozy A; Starling L; Kaski JP; Cervi E
    Front Pediatr; 2022; 10():910660. PubMed ID: 35757141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Normal Electrocardiogram Does Not Exclude Infra-Hisian Conduction Disease in Patients With Myotonic Dystrophy Type 1.
    Creta A; Providência R; Gossios T; Elliott PM; Turner C; Savvatis K; Segal OR
    JACC Clin Electrophysiol; 2021 Aug; 7(8):1038-1048. PubMed ID: 33812832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased temporal dispersion of myocardial repolarization in myotonic dystrophy type 1: beyond the cardiac conduction system.
    Magrì D; Piccirillo G; Bucci E; Pignatelli G; Cauti FM; Morino S; Latino P; Santini D; Marrara F; Volpe M; Antonini G; Testa M
    Int J Cardiol; 2012 May; 156(3):259-64. PubMed ID: 21112106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiologic predictors of sudden death in patients with myotonic dystrophy type 1.
    Rakocevic Stojanovic V; Peric S; Paunic T; Pavlovic S; Cvitan E; Basta I; Peric M; Milicev M; Lavrnic D
    J Clin Neurosci; 2013 Jul; 20(7):1002-6. PubMed ID: 23683744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and clinical characteristics of myotonic dystrophy type 1 in koreans.
    Kim SY; Kim JY; Kim GP; Sung JJ; Lim KS; Lee KW; Chae JH; Hong YH; Seong MW; Park SS
    Korean J Lab Med; 2008 Dec; 28(6):483-92. PubMed ID: 19127114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: a cross-sectional study.
    Petri H; Witting N; Ersbøll MK; Sajadieh A; Dunø M; Helweg-Larsen S; Vissing J; Køber L; Bundgaard H
    Int J Cardiol; 2014 Jun; 174(1):31-6. PubMed ID: 24704412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I.
    Bhakta D; Lowe MR; Groh WJ
    Am Heart J; 2004 Feb; 147(2):224-7. PubMed ID: 14760317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological basis of cardiac arrhythmia in a mouse model of myotonic dystrophy type 1.
    Ginjupalli VKM; Cupelli M; Reisqs JB; Sleiman Y; El-Sherif N; Gourdon G; Puymirat J; Chahine M; Boutjdir M
    Front Physiol; 2023; 14():1257682. PubMed ID: 37811496
    [No Abstract]   [Full Text] [Related]  

  • 17. Ventricular dysfunction in type 1 myotonic dystrophy: electrical, mechanical, or both?
    Lindqvist P; Mörner S; Olofsson BO; Backman C; Lundblad D; Forsberg H; Henein MY
    Int J Cardiol; 2010 Sep; 143(3):378-84. PubMed ID: 19395098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular profile in myotonic dystrophy type 1: Analysis of a case series in a specialized center.
    Gomes L; Pereira T; Martins L
    Rev Port Cardiol; 2014 Dec; 33(12):765-72. PubMed ID: 25481780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiographic predictors of infrahissian conduction disturbances in myotonic dystrophy type 1.
    Joosten IBT; van Lohuizen R; den Uijl DW; Evertz R; de Greef BTA; van Engelen BGM; Faber CG; Vernooy K
    Europace; 2021 Feb; 23(2):298-304. PubMed ID: 33150426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for Cardiac Pacemaker Implantation in Myotonic Dystrophy.
    Hawley RJ; Colleran JA; Fletcher R; Verdino RJ; Kokkinos P; Pinnow E
    MedGenMed; 1999 Sep; ():E5. PubMed ID: 11104407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.